Week 3: CTB Flashcards
Which component in the wall of the aorta is responsible for withstanding high blood pressures due to ejection of blood from the heart?
Elastic Fibres - Allow for stretch under high pressures and recoil under lower pressures
Describe the ideas behind the Epidemiology of Allergies in the developed countries (3)
- Improved hygiene & less parasitic infections
- Vitamin D deficiency
- Dietary changes (later introduction of food items)
Define Hypersensitivity
An inappropriate & excessive immunological reaction to an external antigen due to dysfunctional control of the immune system
Distinguish between Allergy & Anaphylaxis
- Allergy - Local reaction e.g. mucous membranes, skin, lungs
- Anaphylaxis - Systemic reaction (including shock & death)
Define Allergen
Antigen that induces a hypersensitivity reaction
Define Antigen
A biological molecules that induces an immune response
Describe the Classes of Hypersensitivity Reactions
- I - Immediate/IgE-Mediated - IgE binds to predominantly mast cells, eosinophils + basophils - e.g. Allergies, Anaphylaxis, Asthma, Atopy
- II - Anti-body dependent - IgM / IgG
- III - Immune Complex - IC
- IV - Delayed or Cell-Mediated - (Adaptive immune response - T-lymphocytes + macrophages
Give examples of Class I Hypersensitivity reactions
- Allergies (most)
- Anaphylaxis
- Asthma
- Atopy
Give examples of Class II Hypersensitivity reactions
- Autoimmune Haemolytic anaemia
- Goodpasture’s syndrome
- Myasthenia gravis
- Grave’s disease
Give examples of Class III Hypersensitivity reactions
- Serum Sickness
- Extrinsic allergic alveolitis (EAA)
- Rheumatoid arthritis (RA)
- Systemic lupus erythematosus (SLE)
Give examples of Class IV Hypersensitivity reactions
- Allergic contact dermatitis
- Chronic transplant rejection
- Multiple Sclerosis (MS)
- Tuberculin skin test (TST)
Explain the Pathology of the Type I Hypersensitivity Response
- First exposure to allergen
- Antigen activation of TH2 cells and stimulation of IgE class switching B cells
- Production of IgE
- Binding of IgE to FCeRI on mast cells - No response seen in individual but Mast cell STIMULATED
- Second exposure to antigen
- Activation of STIMULATED Mast Cell –> DEGRANULATION: Release of inflammatory mediators including: Cytokines, Vasoactive amines, lipid mediators
- Results in immediate hypersensitivity within minutes and late phase reactions 6-24 hours later
Outline the Pathology of the Type I Hypersensitivity Response
- B cell Stimulation
- IgE Production
- Mast cell Stimulation
- Mast cell Degranulation
What does Degranulation of Mast cells in the Type I Hypersensitivity Response result in?
- Granules with preformed mediators - Degranulate and are released via exocytosis - Vasoactive enzymes + Proteases which cause vascular dilation and smooth muscle contraction and tissue damage
- Lipid Mediators released - Prostaglandins and Leukotrienes - Vascular dilation and smooth muscle constraction
- Cytokines - Inflammation (leukocyte recruitment
Describe Clinical Features of Type I (Immediate/IgE-Mediated) Hypersensitivity Reactions including Allergies
- Sensitisation occurs first, thereafter exposure generates immediate response
- Airway + Eye mucous membranes - Pruritus (itchiness), sneezing, rhinorrhoea (Runny nose), Lacrimation (Runny eyes)
- Skin - Pruritus & urticaria (Also in Type IV reactions)
- Oral & Intestinal Mucous membranes - Pruritus + angioedema (swelling of tissues) - Can be serious
Describe Clinical Features of Type IV (Delayed/Cell-Mediated) Reactions
- Usually T Cytotoxic response (slow+Specific) - Inappropriate + excessive
- Allergic contact dermatitis (best e.g. to learn): Allergens e.g. nickel, metals, latex - Slowly developing, pruritic, localised
- Will remain localised
Outline investigations for Type I Hypersensitivity Reactions
- Type I (immediate/IgE-Mediated) hypersensitivity - Measure blood markers e.g. tryptase, IgE, Eosinophil - Done at time of reaction to determine if an allergic process
- To identify exact allergic in Type I - Skin prick testing (for a range of common allergens): Apply solutions of appropriate test allergens, negative & positive controls (saline & histamine) to skin, prick through solution into skin & read results after 15 mins, Positive result = Lesion >3mm larger than negative control
Outline investigations for Type IV Hypersensitivity Reactions
- Type IV (Delayed/Cell-Mediated) Hypersensitivity - Skin patch testing, can test more than skin prick tests, no picking through skin, patches on back, can apply danders, pollens, medications, metals
- Left on for 2/3 days and then removed, tested against positive and negative controls to define allergens responded to
Outline the Treatments of Hypersensitivity Reactions
- Avoidance: Pollen, house dust mites, animals, insects, foods/drugs, metals
- Mast cell stabilisers - Prevent mast cell deregulation, usually topical (e.g. eye drops, nasal sprays) directly to affected area
- Anti-histamines - Most common - Block histamine receptors & thus effects. Can be topical e.g. eye drops or systemic. Is the most vaso-active
- Steroids - More longer-term/severe, wide-ranging anti-inflammatory effects, Topical or systemic (e.g. hay fever/allergic rhinitis, often in conjunction with Anti-histamines)
- Leukotriene Receptor Antagonists - Block Leukotrine effects, systemic.
- De-sensitisation - ‘Allergen immunotherapy’
Outline the Treatments of Hypersensitivity Reactions
- Avoidance: Pollen, house dust mites, animals, insects, foods/drugs, metals
- Mast cell stabilisers - Prevent mast cell deregulation, usually topical (e.g. eye drops, nasal sprays) directly to affected area
- Anti-histamines - Most common - Block histamine receptors & thus effects. Can be topical e.g. eye drops or systemic. Is the most vaso-active
- Steroids - More longer-term/severe, wide-ranging anti-inflammatory effects, Topical or systemic (e.g. hay fever/allergic rhinitis, often in conjunction with Anti-histamines)
- Leukotriene Receptor Antagonists - Block Leukotrine effects, systemic.
- De-sensitisation - ‘Allergen immunotherapy’
- Anaphylaxis treatment (severe Type I reaction)
Describe De-Sensitisation Treatments for Hypersensitivity reactions
- ‘Allergen Immunotherapy’
- Relies on creating tolerance to allergens by exposure to gradually increasing doses delivered sublingually/subcutaneously
- Requires weekly/monthly treatment for ~3 years
- Risk of anaphylaxis during therapy
Describe Treatment of Anaphylaxis (Severe Type I Reaction)
- Think Airway - Breathing - Circulation - ABC
- Lie patient down - Risk of fainting (due to vasodilator blood, circulating blood widely distributed + some leaking into tissues)
- High-flow oxygen - May have fluid in lungs, constriction of airways
- IV fluids - Vasodilated, fluid leakage, dropping BP –> Anaphylactic shock
- Adrenaline (epinephrine) 500mcg IM (o.5 ml of 1mg/ml) - Antidotes to smooth muscle contraction, vasodilation. IV would have too great effect on heart, Sub-cut would take too long
- IV Anti-histamine (chlorphenamine)
- IV Steroid (Hydrocortisone)
- Nebulised Bronchodilator (salbutamol) - bronchoconstriction
- Repeat Adrenaline IM if no improvement after 5 mins
What generates the Electrical Impulse in the Heart?
- Sinoatrial Node - Where electrical signal originates (pacemaker of heart)
- Strip of specialised myocytes 20mm x 4mm long
- Located on posterior wall of RA close to SVC
- Has Intrinsic Automaticity (can spontaneously generate APs) which are propagated to surrounding atrial tissue and internodal pathways
- Discharge rate 70-80bpm
- Drives sinus rhythm
What are the internodal pathways of conduction?
- Propagate electrical impulses from SAN to the AV nodes